Henrike Siebels1, Christian Sohns2, Jan-Hendrik Nürnberg1, Jürgen Siebels1, Klaus Langes1, Joachim Hebe1. 1. Department of Electrophysiology, Electrophysiology Center Bremen, Senator-Weßling-Str. 1, 28277, Bremen, Germany. 2. Department of Electrophysiology, Electrophysiology Center Bremen, Senator-Weßling-Str. 1, 28277, Bremen, Germany. c.sohns@ep-bremen.com.
Abstract
PURPOSE: Radiofrequency current energy (RFC) ablation is still considered as the gold standard for atrioventricular nodal reentrant tachycardia (AVNRT). Success-rates for AVNRT ablation vary irrespective of the ablation technology and strategy. This study aimed to access safety, efficacy, and long-term outcome of RFC catheter ablation for the treatment of AVNRT in children and adolescents aged < 19 years with special focus on modulation versus ablation of the AV nodal slow pathway (SP). METHODS: A total number of 1143 patients (pts) < 19 years were referred for invasive electrophysiological testing due to paroxysmal supraventricular tachycardia (SVT). RESULTS: Diagnosis of AVNRT was confirmed in 412 pts, and RFC-guided ablation was attempted in 386 pts (age 13.0 ± 3.5 years). No permanent complications were observed. RFC application resulted in SP-ablation in 171/386 (44.3%) and in SP modulation in 208/386 (53.9%) children, whereas attempts for RFC treatment failed in 7 pts. Follow-up was completed for 396/412 patients (96.1%). Within a mean follow-up period of 54.9 ± 39.7 months, in 51/379 pts (13.5%) AVNRT recurrence was observed. The median time until tachycardia recurrence was 19.5 months. No difference for AVNRT recurrence was found comparing SP ablation versus SP modulation (p > 0.05), whereas the recurrence rate was significantly higher in patients with non-inducible SVT and therefore empiric SP treatment as compared to patients with inducible AVNRT (p = 0.01). CONCLUSIONS: RFC-guided ablation for AVNRT in children and adolescents is safe and leads to an acceptable long-term freedom from recurrences. SP modulation and SP ablation resulted in comparable acute and long-term success rates. Late AVNRT recurrences can occur even after years of freedom from tachycardia-related symptoms.
PURPOSE: Radiofrequency current energy (RFC) ablation is still considered as the gold standard for atrioventricular nodal reentrant tachycardia (AVNRT). Success-rates for AVNRT ablation vary irrespective of the ablation technology and strategy. This study aimed to access safety, efficacy, and long-term outcome of RFC catheter ablation for the treatment of AVNRT in children and adolescents aged < 19 years with special focus on modulation versus ablation of the AV nodal slow pathway (SP). METHODS: A total number of 1143 patients (pts) < 19 years were referred for invasive electrophysiological testing due to paroxysmal supraventricular tachycardia (SVT). RESULTS: Diagnosis of AVNRT was confirmed in 412 pts, and RFC-guided ablation was attempted in 386 pts (age 13.0 ± 3.5 years). No permanent complications were observed. RFC application resulted in SP-ablation in 171/386 (44.3%) and in SP modulation in 208/386 (53.9%) children, whereas attempts for RFC treatment failed in 7 pts. Follow-up was completed for 396/412 patients (96.1%). Within a mean follow-up period of 54.9 ± 39.7 months, in 51/379 pts (13.5%) AVNRT recurrence was observed. The median time until tachycardia recurrence was 19.5 months. No difference for AVNRT recurrence was found comparing SP ablation versus SP modulation (p > 0.05), whereas the recurrence rate was significantly higher in patients with non-inducible SVT and therefore empiric SP treatment as compared to patients with inducible AVNRT (p = 0.01). CONCLUSIONS: RFC-guided ablation for AVNRT in children and adolescents is safe and leads to an acceptable long-term freedom from recurrences. SP modulation and SP ablation resulted in comparable acute and long-term success rates. Late AVNRT recurrences can occur even after years of freedom from tachycardia-related symptoms.
Authors: Christian Pott; Felix K Wegner; Nils Bögeholz; Gerrit Frommeyer; Dirk G Dechering; Stephan Zellerhoff; Simon Kochhäuser; Peter Milberg; Julia Köbe; Kristina Wasmer; Günter Breithardt; Gerold Mönnig; Lars Eckardt Journal: Clin Res Cardiol Date: 2015-05-21 Impact factor: 5.460
Authors: Kathryn K Collins; Anne M Dubin; Nancy A Chiesa; Kishor Avasarala; George F Van Hare Journal: Heart Rhythm Date: 2006-02-28 Impact factor: 6.343
Authors: George F Van Hare; Harold Javitz; Dorit Carmelli; J Philip Saul; Ronn E Tanel; Peter S Fischbach; Ronald J Kanter; Michael Schaffer; Ann Dunnigan; Steven Colan; Gerald Serwer Journal: J Cardiovasc Electrophysiol Date: 2004-07
Authors: Edward T O'Leary; Jamie Harris; Kimberlee Gauvreau; Courtney Gentry; Audrey Dionne; Dominic J Abrams; Mark E Alexander; Vassilios J Bezzerides; Elizabeth S DeWitt; John K Triedman; Edward P Walsh; Douglas Y Mah Journal: J Am Heart Assoc Date: 2022-06-14 Impact factor: 6.106
Authors: Kevin Willy; Gerrit Frommeyer; Dirk G Dechering; Kristina Wasmer; Dennis Höwel; Sarah S Welle; Nils Bögeholz; Christian Ellermann; Julian Wolfes; Benjamin Rath; Patrick R Leitz; Julia Köbe; Philipp S Lange; Patrick Müller; Florian Reinke; Lars Eckardt Journal: Clin Cardiol Date: 2020-08-31 Impact factor: 2.882